Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments.

Janiszewska M, Tabassum DP, Castaño Z, Cristea S, Yamamoto KN, Kingston NL, Murphy KC, Shu S, Harper NW, Del Alcazar CG, Alečković M, Ekram MB, Cohen O, Kwak M, Qin Y, Laszewski T, Luoma A, Marusyk A, Wucherpfennig KW, Wagle N, Fan R, Michor F, McAllister SS, Polyak K.

Nat Cell Biol. 2019 Jul;21(7):879-888. doi: 10.1038/s41556-019-0346-x. Epub 2019 Jul 1.

PMID:
31263265
2.

Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.

Ding L, Shunkwiler LB, Harper NW, Zhao Y, Hinohara K, Huh SJ, Ekram MB, Guz J, Kern MJ, Awgulewitsch A, Shull JD, Smits BMG, Polyak K.

PLoS Genet. 2019 Mar 20;15(3):e1008002. doi: 10.1371/journal.pgen.1008002. eCollection 2019 Mar.

3.

High-Throughput Targeted Repeat Element Bisulfite Sequencing (HT-TREBS).

Bakshi A, Ekram MB, Kim J.

Methods Mol Biol. 2019;1908:219-228. doi: 10.1007/978-1-4939-9004-7_15.

PMID:
30649731
4.

TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.

Witwicki RM, Ekram MB, Qiu X, Janiszewska M, Shu S, Kwon M, Trinh A, Frias E, Ramadan N, Hoffman G, Yu K, Xie Y, McAllister G, McDonald R, Golji J, Schlabach M, deWeck A, Keen N, Chan HM, Ruddy D, Rejtar T, Sovath S, Silver S, Sellers WR, Jagani Z, Hogarty MD, Roberts C, Brown M, Stegmaier K, Long H, Shivdasani RA, Pellman D, Polyak K.

Cell Rep. 2018 Oct 30;25(5):1255-1267.e5. doi: 10.1016/j.celrep.2018.10.023.

5.

LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.

Liang Y, Ahmed M, Guo H, Soares F, Hua JT, Gao S, Lu C, Poon C, Han W, Langstein J, Ekram MB, Li B, Davicioni E, Takhar M, Erho N, Karnes RJ, Chadwick D, van der Kwast T, Boutros PC, Arrowsmith CH, Feng FY, Joshua AM, Zoubeidi A, Cai C, He HH.

Cancer Res. 2017 Oct 15;77(20):5479-5490. doi: 10.1158/0008-5472.CAN-17-0496. Epub 2017 Sep 15.

6.

Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.

Gil Del Alcazar CR, Huh SJ, Ekram MB, Trinh A, Liu LL, Beca F, Zi X, Kwak M, Bergholtz H, Su Y, Ding L, Russnes HG, Richardson AL, Babski K, Min Hui Kim E, McDonnell CH 3rd, Wagner J, Rowberry R, Freeman GJ, Dillon D, Sorlie T, Coussens LM, Garber JE, Fan R, Bobolis K, Allred DC, Jeong J, Park SY, Michor F, Polyak K.

Cancer Discov. 2017 Oct;7(10):1098-1115. doi: 10.1158/2159-8290.CD-17-0222. Epub 2017 Jun 26.

7.

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.

Shu S, Lin CY, He HH, Witwicki RM, Tabassum DP, Roberts JM, Janiszewska M, Huh SJ, Liang Y, Ryan J, Doherty E, Mohammed H, Guo H, Stover DG, Ekram MB, Brown J, D'Santos C, Krop IE, Dillon D, McKeown M, Ott C, Qi J, Ni M, Rao PK, Duarte M, Wu SY, Chiang CM, Anders L, Young RA, Winer E, Letai A, Barry WT, Carroll JS, Long H, Brown M, Liu XS, Meyer CA, Bradner JE, Polyak K.

Nature. 2016 Jan 21;529(7586):413-417. doi: 10.1038/nature16508. Epub 2016 Jan 6.

9.

AEBP2 as a transcriptional activator and its role in cell migration.

Kim H, Ekram MB, Bakshi A, Kim J.

Genomics. 2015 Feb;105(2):108-15. doi: 10.1016/j.ygeno.2014.11.007. Epub 2014 Nov 28.

10.

High-throughput targeted repeat element bisulfite sequencing (HT-TREBS): genome-wide DNA methylation analysis of IAP LTR retrotransposon.

Ekram MB, Kim J.

PLoS One. 2014 Jul 8;9(7):e101683. doi: 10.1371/journal.pone.0101683. eCollection 2014.

11.

JARID1B is a luminal lineage-driving oncogene in breast cancer.

Yamamoto S, Wu Z, Russnes HG, Takagi S, Peluffo G, Vaske C, Zhao X, Moen Vollan HK, Maruyama R, Ekram MB, Sun H, Kim JH, Carver K, Zucca M, Feng J, Almendro V, Bessarabova M, Rueda OM, Nikolsky Y, Caldas C, Liu XS, Polyak K.

Cancer Cell. 2014 Jun 16;25(6):762-77. doi: 10.1016/j.ccr.2014.04.024.

12.

Peg3 mutational effects on reproduction and placenta-specific gene families.

Kim J, Frey WD, He H, Kim H, Ekram MB, Bakshi A, Faisal M, Perera BP, Ye A, Teruyama R.

PLoS One. 2013 Dec 31;8(12):e83359. doi: 10.1371/journal.pone.0083359. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/8de03ec5-e62c-4135-87ee-4928475090a8.

13.

DNA-binding motif and target genes of the imprinted transcription factor PEG3.

Thiaville MM, Huang JM, Kim H, Ekram MB, Roh TY, Kim J.

Gene. 2013 Jan 10;512(2):314-20. doi: 10.1016/j.gene.2012.10.005. Epub 2012 Oct 16.

14.

Retrotransposons as a major source of epigenetic variations in the mammalian genome.

Ekram MB, Kang K, Kim H, Kim J.

Epigenetics. 2012 Apr;7(4):370-82. doi: 10.4161/epi.19462. Epub 2012 Apr 1.

15.

Imprinting control region (ICR) of the Peg3 domain.

Kim J, Ekram MB, Kim H, Faisal M, Frey WD, Huang JM, Tran K, Kim MM, Yu S.

Hum Mol Genet. 2012 Jun 15;21(12):2677-87. doi: 10.1093/hmg/dds092. Epub 2012 Mar 6.

16.

Aebp2 as an epigenetic regulator for neural crest cells.

Kim H, Kang K, Ekram MB, Roh TY, Kim J.

PLoS One. 2011;6(9):e25174. doi: 10.1371/journal.pone.0025174. Epub 2011 Sep 19.

17.

Rex1/Zfp42 as an epigenetic regulator for genomic imprinting.

Kim JD, Kim H, Ekram MB, Yu S, Faulk C, Kim J.

Hum Mol Genet. 2011 Apr 1;20(7):1353-62. doi: 10.1093/hmg/ddr017. Epub 2011 Jan 13.

Supplemental Content

Loading ...
Support Center